How do families affected by MS manage health information?
The study in brief
In this study, UK researchers wanted to understand how couples and families affected by MS cope with health information.
The researchers analysed interviews with 77 people affected by MS – 12 people with MS, 49 partners or spouses, 7 parents, 5 children, 2 siblings and 2 friends.
Interviewees regularly stated that information was critical for living well with MS but at the same time the quantity was seen as overwhelming, time-consuming and, at times, emotionally distressing.
Couples and families developed their own unique ways of dealing with health information, reflecting family relationships, personal preferences and technical abilities. In most families, one person took the lead. Differences in attitudes to receiving or sharing health-related information could lead to family tensions. Information was withheld or modified when it was deemed too upsetting for other members of the family, especially children and older relatives.
The study shows that when someone is faced with living with a long-term condition like MS, family members and close friends can play a vital role, seeking out, sharing and managing information. It may be helpful for health professionals to find out who is the key “information worker” within a family, to ensure that they, as well as the person with MS, receive the necessary information.
Managing health information is a significant but demanding aspect of living with MS and should be recognised as such, but the researchers warn against assuming that simply providing more information gives people more power or control over their health care and decisions about treatments.
The study in more detail
Background
Finding and interpreting health information has become an increasingly important part of living with MS as a result of a growing emphasis on self-management, where people with MS are encouraged to take a pro-active role in managing their own health and sharing decisions about treatments. Previously, studies have looked at how the person with MS manages information about their condition but there has been very little research into the role played by family members and close friends. In this study, researchers wanted to understand how couples and families affected by MS respond to and manage health-related information within the family unit.
How this study was carried out
The UK researchers analysed interviews with 77 people affected by MS – 12 people with MS, 49 partners or spouses, 7 parents, 5 children, 2 siblings and 2 friends. The researchers recruited as wide a range of people as possible in terms of age, ethnicity, gender and length of time since diagnosis. Almost all interviewees were older than 30 years.
To limit the scope of the analysis, the researchers focussed on health information practices within the family, for example how couples share health information with each other.
What was found?
Interviewees regularly stated that information was critical for living well with MS but at the same time the sheer quantity was perceived as overwhelming, time-consuming and, at times, emotionally distressing.
Couples and families developed their own unique approaches to dealing with health information, reflecting relationships between family members, personal preferences and technical abilities.
A key finding was that, at any given time, one person (usually either the person with MS or their partner) took primary responsibility for managing the flow of information into, within and beyond the family. When one member of a couple avoided or ignored information, the other usually compensated by taking on the responsibility for managing it. Where the person with MS was an avid information seeker, other family members tended to take a back seat, allowing the person with MS to take the lead.
MS was often seen as something a couple or family faced together, and sharing a life with MS often went hand-in-hand with sharing information about it, one partner describing how he and his wife who has MS sat down together and went through news stories about MS with a fine-tooth comb.
However, this was not always the case and differences in approach to health-related information could result in tensions. This was especially true where one or more family member (commonly the person with MS) resisted receiving or sharing health-related information. Other family members felt they had to encourage or sometimes force the resistant person to be more involved.
Partners sometimes did not feel comfortable requesting information as they were not the person with MS and felt that to do so would be an invasion of privacy; others spoke of disclosing or obtaining information irrespective of the wishes of the person with MS because they felt it was in their best interests and saw it as an aspect of caring.
Some couples controlled the volume of information by agreeing to be selective, perhaps restricting themselves to one aspect of life, a particular website or support network (such as a Facebook group), or a trusted heath professional. Changes in the course of MS or lifestyle triggered more information seeking which then tapered off until the next trigger. Interviewees described numerous instances when they had withheld or modified information they felt could be upsetting for other members of the family, especially children and older relatives.
Access to online resources, such as the internet, social media and patient forums, were seen as both good and bad; while they enabled access to information, support from other people with MS and news about medical research, they were also viewed as potentially spreading misinformation, time-consuming and dependent on technical skills.
What does it mean?
This study shows that when somebody is faced with living with a long-term condition like MS, family members and close friends can play a vital role, seeking out, sharing and managing information.
Couples and families develop their own unique approach to dealing with health information, so it’s important that a variety of options and services are available which people can access when it is needed. It may be helpful for health professionals to find out who is the key “information worker” within a family, to ensure that they, as well as the person with MS, receives the necessary information.
Managing health information is a significant but demanding aspect of living with MS and should be recognised as such, but the researchers warn against assuming that simply providing more information gives people more power or control over their health care and decisions about treatments.
Mazanderani F, Hughes N, Hardy C, et al.
Health information work and the enactment of care in couples and families affected by multiple sclerosis.
Sociology of Health & Illness 2019; 41: 395-410.
Summary
Information to help you manage MS
MS is a complex condition that affects everyone differently. You’re the best person to know what helps you on a day to day basis – we want to give you the resources and information to enable you to do that, and to live well with your MS.
With a long-term condition like MS, you may see health professionals more or less frequently, but MS is with you all year round. Self-management, to us, means all the things that you can do for yourself in between visits to your neurologist, doctors or nurses.
If you have any questions and would like to speak to someone, please contact our Information Service on 0800 032 38 39 or email ask@mstrust.org.uk
We are here to support you. We can answer your questions about multiple sclerosis and life with the condition. You may have MS yourself or be a friend or family member of someone with the condition.
Browse more from the latest research
Diagnosis
Kaisey M, Solomon AJ, Luu M, et al.
Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers.
Mult Scler Relat Disord. 2019 Feb 2;30:51-56. [Epub ahead of print]
Summary
Wijnands JMA, Zhu F, Kingwell E, et al.
The prodrome in relapsing remitting and primary progressive multiple sclerosis.
Eur J Neurol. 2019 Feb 3. [Epub ahead of print]
Summary
Vecchio D, Naldi P, Ferro V, et al.
Post-lumbar puncture headache: an adverse effect in multiple sclerosis work-up.
Neurol Sci. 2019 Jan 21. [Epub ahead of print]
Summary
Lavandier N, Bonnan M, Carra-Dallière C, et al.
First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study.
Mult Scler Relat Disord. 2018 Dec 14;28:309-312. [Epub ahead of print]
Summary
Disease modifying drugs
Phyo AZZ, Jelinek GA, Brown CR, et al.
Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life.
Mult Scler Relat Disord. 2019 Jan 24;30:25-32. [Epub ahead of print]
Summary
Full article
Cohan SL, Edwards K, Lucas L, et al.
Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy.
Mult Scler J Exp Transl Clin. 2019 Jan 16;5(1):2055217318824618.
Summary
Full article
Naismith RT, Hendin B, Wray S, et al.
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results.
Mult Scler J Exp Transl Clin. 2019 Jan 30;5(1):2055217318822148.
Summary
Full article
Min J, Cohan S, Alvarez E, et al.
Real-world characterization of dimethyl fumarate-related gastrointestinal events in multiple sclerosis: management strategies to improve persistence on treatment and patient outcomes.
Neurol Ther. 2019 Jan 31. [Epub ahead of print]
Summary
Full article
Claflin SB, Broadley S, Taylor BV.
The effect of disease modifying therapies on disability progression in multiple sclerosis: a systematic overview of meta-analyses.
Front Neurol. 2019 Jan 10;9:1150.
Summary
Full article
McCool R, Wilson K, Arber M, et al.
Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis.
Mult Scler Relat Disord. 2019 Jan 2;29:55-61. [Epub ahead of print]
Summary
Full article
Epidemiology
Stenager E.
A global perspective on the burden of multiple sclerosis.
Lancet Neurol. 2019 Jan 21. pii: S1474-4422(18)30498-8. [Epub ahead of print]
Summary
Full article
GBD 2016 Multiple Sclerosis Collaborators..
Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Neurol. 2019 Jan 21. pii: S1474-4422(18)30443-5. [Epub ahead of print]
Summary
Full article
Islam MM, Poly TN, Yang HC, et al.
Increase Risk of multiple sclerosis in patients with psoriasis disease: an evidence of observational studies.
Neuroepidemiology. 2019 Jan 22;52(3-4):152-160. [Epub ahead of print]
Summary
Other treatments
Wahls TL, Chenard CA, Snetselaar LG.
Review of two popular eating plans within the multiple sclerosis community: low saturated fat and modified paleolithic.
Nutrients. 2019 Feb 7;11(2). pii: E352.
Summary
Full article
Paediatric MS
Parrish JB, Fields E.
Cognitive functioning in patients with pediatric-onset multiple sclerosis, an updated review and future focus.
Children (Basel). 2019 Feb 4;6(2). pii: E21.
Summary
Full article
Papetti L, Figà Talamanca L, Spalice A, et al.
Predictors of evolution into multiple sclerosis after a first acute demyelinating syndrome in children and adolescents.
Front Neurol. 2019 Jan 15;9:1156.
Summary
Full article
Prognosis
Briggs FBS, Thompson NR, Conway DS.
Prognostic factors of disability in relapsing remitting multiple sclerosis.
Mult Scler Relat Disord. 2019 Jan 29;30:9-16. [Epub ahead of print]
Summary
Provision of care
Frahm N, Hecker M, Zettl UK.
Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.
PLoS One. 2019 Jan 24;14(1):e0211120.
Summary
Full article
Psychological aspects
Yalachkov Y, Soydaş D, Bergmann J, et al.
Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
Mult Scler Relat Disord. 2019 Jan 30;30:33-37. [Epub ahead of print]
Summary
Broadbent FJ, Swalwell JM.
"I can do more than I thought I could": exploring the online blogs from the Sailing Sclerosis Oceans of Hope journey.
Disabil Rehabil. 2019 Feb 1:1-7. [Epub ahead of print]
Summary
Van Damme S, Kindt S, Crombez G, et al.
The relation between goal adjustment, goal disturbance, and mental well-being among persons with multiple sclerosis.
Psychol Health. 2019 Jan 26:1-16. [Epub ahead of print]
Summary
Di Cara M, Lo Buono V, Corallo F, et al.
Body image in multiple sclerosis patients: a descriptive review.
Neurol Sci. 2019 Jan 22. [Epub ahead of print]
Summary
Hyarat SY, Subih M, Rayan A, et al.
Health related quality of life among patients with multiple sclerosis: the role of psychosocial adjustment to illness.
Arch Psychiatr Nurs. 2019 Feb;33(1):11-16.
Summary
Rehabilitation
Arntzen EC, Straume BK, Odeh F, et al.
Group-based individualized comprehensive core stability intervention improves balance in persons with multiple sclerosis: a randomized controlled trial.
Phys Ther. 2019 Feb 4. [Epub ahead of print]
Summary
Full article
Van Liew C, Dibble LE, Hunt GR, et al.
Protective stepping in multiple sclerosis: Impacts of a single session of in-place perturbation practice.
Mult Scler Relat Disord. 2019 Jan 30;30:17-24. [Epub ahead of print]
Summary
Callesen J, Dalgas U, Brincks J, et al.
How much does balance and muscle strength impact walking in persons with multiple sclerosis? - A cross-sectional study.
Mult Scler Relat Disord. 2019 Jan 24;29:137-144. [Epub ahead of print]
Summary
Moghadasi A, Ghasemi G, Sadeghi-Demneh E, et al.
The effect of total body resistance exercise on mobility, proprioception and muscle strength of the knee in people with multiple sclerosis.
J Sport Rehabil. 2019 Jan 24:1-22. [Epub ahead of print]
Summary
Merali S, Cameron JI, Barclay R, et al.
Experiences of people with stroke and multiple sclerosis and caregivers of a community exercise programme involving a healthcare-recreation partnership.
Disabil Rehabil. 2019 Jan 22:1-7. [Epub ahead of print]
Summary
Self-management
Apolinário-Hagen J, Menzel M, Hennemann S, et al.
Acceptance of mobile health apps for disease management among people with multiple sclerosis: web-based survey study.
JMIR Form Res. 2018 Dec 12;2(2):e11977.
Summary
Full article
Stem cells
Nagpal A, Milte R, Kim SW, et al.
Economic evaluation of stem cell therapies in neurological diseases: a systematic review.
Value Health. 2019 Feb;22(2):254-262.
Summary
Symptoms and symptom management
Sakkas GK, Giannaki CD, Karatzaferi C, et al.
Sleep Abnormalities in Multiple Sclerosis.
Curr Treat Options Neurol. 2019 Jan 31;21(1):4.
Summary
Tarameshlu M, Ghelichi L, Azimi AR, et al.
The effect of traditional dysphagia therapy on the swallowing function in patients with multiple mclerosis: A pilot double-blinded randomized controlled trial.
J Bodyw Mov Ther. 2019 Jan;23(1):171-176.
Summary
Full article
Asplund P, Linderoth B, Lind G, et al.
One hundred eleven percutaneous balloon compressions for trigeminal neuralgia in a cohort of 66 patients with multiple sclerosis.
Oper Neurosurg (Hagerstown). 2019 Jan 23. [Epub ahead of print]
Summary
Chaseling GK, Allen DR, Vucic S, et al.
Core temperature is not elevated at rest in people with relapsing-remitting multiple sclerosis.
Mult Scler Relat Disord. 2019 Jan 4;29:62-67. [Epub ahead of print]
Summary
Vitamin D
Kotb MA, Kamal AM, Aldossary NM, et al.
Effect of vitamin D replacement on depression in multiple sclerosis patients.
Mult Scler Relat Disord. 2019 Jan 23;29:111-117. [Epub ahead of print]
Summary
Work
Kavaliunas A, Tinghög P, Friberg E, et al.
Cognitive function predicts work disability among multiple sclerosis patients.
Mult Scler J Exp Transl Clin. 2019 Jan 14;5(1):2055217318822134.
Summary
Full article
Incerti CC, Argento O, Magistrale G, et al.
Can personality traits influence occupational stress in multiple sclerosis patients? A one-year longitudinal study.
Appl Neuropsychol Adult. 2019 Feb 5:1-3. [Epub ahead of print]
Summary


Ozanimod (Zeposia) approved for relapsing remitting MS in Scotland
8 Feb 2021 - 00:00
The MS Trust is delighted that ozanimod (Zeposia) has been approved in Scotland for people with active relapsing remitting multiple sclerosis.


Exercise is good for your brain
3 Feb 2021 - 00:00
There is more to exercise than physical fitness. This review looks at recent research which shows how exercise has a direct beneficial effect on brain repair processes.


Covid-19 vaccines and MS: Part two
29 Jan 2021 - 00:00
Following our last interview on the subject of the Covid-19 vaccine and people with MS, we received a lot of follow up questions. To answer some of these, we spoke once again to Professor Alasdair Coles, Consultant Neurologist at Addenbrooke’s hospital.

Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.